Skip to main content
Log in

Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

A recently established model for local breast cancer recurrence using the 13762NF rat mammary adenocarcinoma was used to evaluate biologic and biochemical properties related to clinical outcome for this class of tumors. Sublines isolated from local tumor regrowths following surgical resection differed from each other and from the ‘parental’ cell lines for multiple phenotypes, including metastatic propensity. Local recurrence- and primary tumor-derived sublines were examined by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE), lectin binding to electrophoretically separated proteins, and lactoperoxidase-catalyzed cell surface iodination; and differential protein patterns were compared to tumor progression and metastatic potential. 2D-PAGE revealed several quantitatively different spots which correlated with lung colonization potential. In particular, quantities of an apparently unique, non-cell-surface protein, P50.9 (M r ∼ 50 900, pI ∼ 7·3) correlated inversely with metastatic propensity, suggesting that it may be associated with, among other possibilities, the negative regulation of the metastatic phenotype. P50.9 was unrelated to four similarly sized metastasis-associated proteins—tumor autocrine motility factor; the rat analog of tumor suppressor, p53; rat cytokeratin 14 or procathepsin D—as determined by amino acid analysis. A major wheat germ agglutinin binding sialoglycoprotein, gp93 (M r ∼ 93 000), was present in smaller amounts as cells were passaged in vivo and re-established as in vitro cultures [MTF7 > ‘primary’ tumor-derived lines (scl, sc3) ≫ local recurrence-derived lines (LR1, LRla, LR3, LR4, LR5, LR6)]. Besides cell surface glycoprotein losses, two of six local recurrence-derived sublines expressed a wheat germ agglutinin-binding sialoglycoprotein, gp110 (M r ∼ 110000), previously undetected on any of the other cell lines including the parental populations. gp110 was found in LR3 and LR6 which were relatively highly metastatic; however, correlation with metastatic potential failed because gp110 was not present on the metastatic parental cell line, MTF7. These results demonstrate specific quantitative and qualitative protein differences associated with the selection of locally recurrent mammary tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adams, L. D., 1987, Two-dimensional gel electrophoresis using the ISO-DALT system. Current Protocols in Molecular Biology, edited by A. Ausubelet al. (New York: Greene Publishing Associates and Wiley Interscience), pp. 10.3.1–10.3.12.

    Google Scholar 

  2. Anderson, N. G., and Anderson, N. L., 1978, Analytical techniques for cell fractionations. XXI. Two dimensional analysis of serum and tissue proteins: multiple isoelectric focusing. Analytical Biochemistry, 85, 331–340.

    Google Scholar 

  3. Anderson, N. L., and Anderson, N. G., 1978, Analytical techniques for cell fractionations. XXII. Two dimensional analysis of serum and tissue proteins: multiple gradient-slab gel electrophoresis. Analytical Biochemistry, 85, 341–354.

    Google Scholar 

  4. Augereau, P., Garcia, M., Mattei, M. G., Cavailles, V., Depadova, J., Derocq, D., Capony, F., Ferrara, P., and Rochefort, H., 1988, Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11. Molecular Endocrinology, 2, 186–192.

    Google Scholar 

  5. Briozzo, P., Morisset, M., Capony, F., Rougeot, C., and Rochefort, H., 1988, In vitro degradation of extracellular matrix with Mr 52,000 cathepsin D secreted by breast cancer cells. Cancer Research, 48, 3688–3692.

    Google Scholar 

  6. Burridge, K., 1978, Direct identification of specific glycoproteins and antigens in sodium dodecyl sulfate gels. Methods in Enzymology, 50, 54–64.

    Google Scholar 

  7. Cornish-Bowden, A., 1983, Relating proteins by amino acid composition. Methods in Enzymology, 91, 60–75.

    Google Scholar 

  8. Dear, R. N., Ramshaw, I. A., and Kifford, R. F., 1988, Differential expression of a novel gene, WDNMI, in nonmetastatic rat mammary adenocarcinoma cells. Cancer Research, 48, 5203–5209.

    Google Scholar 

  9. Dennis, J. W., and Laferte, S., 1989, Oncodevelopmental expression of-GlcNAcβ1–6Manα1–6Manβ1-branched asparagine-lined oligosaccharides in murine tissues and human breast carcinomas. Cancer Research, 49, 945–950.

    Google Scholar 

  10. Estrada, J., Freeman, D., Reed, P. A., and Welch, D. R., 1989, Characterization of a model for locally recurring mammary tumors: I. Development, morphology, karyotype, growth kinetics and experimental metastatic potential. Cancer, 63, 1353–1362.

    Google Scholar 

  11. Faust, P. L., Kornfeld, S., and Chirgwen, J. M., 1985, Cloning and sequence analysis of cDNA for human cathepsin D. Proceedings of the National Academy of Sciences, U.S.A., 82, 4910–4914.

    Google Scholar 

  12. Fidler, I. J., 1978, General considerations for studies of experimental metastasis. Methods in Cancer Research, 15, 399–439.

    Google Scholar 

  13. Hoogstraten, B., Gad-el-Mawla, N., Maloney, T. R., Fletcher, W. S., Vaughn, T., Tranun, B. L., Athens, J. W., and Costanzi, J. J., 1984, Combined modality therapy for first recurrence of breast cancer. A Southwest Oncology Group Study. Cancer, 54, 2248–2256.

    Google Scholar 

  14. Hubbard, A. L., and Cohn, Z. A., 1975, Externally disposed plasma membrane proteins. I. Enzymatic iodination of mouse L cells. Journal of Cell Biology, 64, 438–460.

    Google Scholar 

  15. Humphries, M. J., Matsumoto, K., White, S. L., and Olden, K., 1986, Inhibition of experimental metastasis by castanospermine in mice: blockage of two distinct stages of tumor colonization by oligosaccharide processing inhibitors. Cancer Research, 46, 5215–5222.

    Google Scholar 

  16. Hunkapiller, M. W., Lujan, E., Ostrander, F., and Hood, L. E., 1983, Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis. Methods in Enzymology, 91, 227–236.

    Google Scholar 

  17. Irimura, T., and Nicolson, G. L., 1983, Carbohydrate chain analysis by lectin binding to mixtures of glycoproteins separated by PAGE with in situ chemical modifications. Carbohydrate Research, 115, 209–220.

    Google Scholar 

  18. Karabali-Dalamaga, S., Souhami, R. L., O'Higgins, N. J., Soumilas, A., and Clark, C. G., 1979, Natural history and prognosis of recurrent breast cancer. British Journal of Medicine, 2, 730–733.

    Google Scholar 

  19. Laemmli, U. K., 1970, Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London), 227, 680–685.

    Google Scholar 

  20. Le Grue, S. J., 1982, 1-Butanol extraction and subsequent reconstitution of membrane components which mediate metastatic phenotype. Cancer Research, 42, 2126–2134.

    Google Scholar 

  21. Lichtner, R. B., Julian, J. A., Glasser, S. R., and Nicolson, G. L., 1989, Characterization of cytokeratins expressed in metastasizing rat mammary adenocarcinoma cells. Cancer Research, 49, 104–111.

    Google Scholar 

  22. Liotta, L. A., Maladler, R., Murano, G., Katz, D. A., Gordon, R. K., Chiang, P. K., and Schiffmann, E., 1986, Tumor cell autocrine motility factor. Proceedings of the National Academy of Sciences, U.S.A., 83, 3302–3306.

    Google Scholar 

  23. Miner, K. M., Kawaguchi, T., Uba, G. W., and Nicolson, G. L., 1982, Clonal drift of cell surface, melanogenic and experimental metastatic properties of in vivo-selected brain meninges-colonizing muring B16 melanoma. Cancer Research, 42, 4631–4636.

    Google Scholar 

  24. Morisset, M., Capony, F., and Rochefort, H., 1986, The 52-kDa estrogen-induced protein secreted by MCF7 cells is a lysosomal acidic protease. Biochemical and Biophysical Research Communiations, 138, 102–109.

    Google Scholar 

  25. Neri, A., Welch, D. R., Kawaguchi, T., and Nicolson, G. L., 1982, The development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. Journal of the National Cancer Institute, 68, 507–517.

    Google Scholar 

  26. Nicolson, G. L., 1982, Cell surfaces and cancer metastasis. Hospital Practice, 17, 75–86.

    Google Scholar 

  27. Nicolson, G. L., Labiche, R. K., Frazier, M. L., Blick, M., Tressler, R. J., Reading, C. L., Irimura, T., and Rotter, V., 1986, Differential gene expression of metastasis-associated cell surface glycoproteins and mRNA in a large cell lymphoma. Journal of Cellular Biochemistry, 31, 305–312.

    Google Scholar 

  28. Nicolson, G. L., and Lotan, R., 1986, Preventing diversification of malignant tumor cells during therapy. Clinical and Experimental Metastasis, 4, 231–235.

    Google Scholar 

  29. Nicolson, G. L., Mascali, J. J., and McGuire, E. J., 1982, Metastatic RAW117 lymphosarcoma as a model for malignant normal cell interactions. Possible role for cell surface antigens in determining the quantity and location of secondary tumors. Oncodevelopmental Biology and Medicine, 4, 149–159.

    Google Scholar 

  30. Nicolson, G. L., and Poste, G., 1982, Tumor cell diversity and host responses in cancer metastasis. I. Properties of metastatic cells. Current Problems in Cancer, 7, 1–83.

    Google Scholar 

  31. Nicolson, G. L., and Posts, G., 1983, Tumor cell diversity and host responses in cancer metastasis. II. Host immune responses and therapy of metastasis. Current Problems in Cancer, 7, 1–42.

    Google Scholar 

  32. Penno, M. B., Passaniti, A., Fridman, R., Hart, G. W., Jordan, C., Kuman, S., and Scott, A. F., 1989, In vitro galactosylation of a 110-kDa glycoprotein by an endogenous cell surface galactosyltransferase correlates with the invesiveness of adrenal carcinoma cells. Proceedings of the National Academy of Sciences, U.S.A., 86, 6057–6061.

    Google Scholar 

  33. Pohl, J., Goldfinger, N., Radler-Pohl, A., Rotter, V., and Schirrmacher, V., 1988, p53 increases experimental metastatic capacity of murine carcinoma cells. Molecular and Cellular Biology, 8, 2078–2081.

    Google Scholar 

  34. Posts, G., Doll, J., and Fidler, I. J., 1981, Interactions among clonal subpopulations affect the stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. Proceedings of the National Academy of Sciences, U.S.A., 78, 6226–6230.

    Google Scholar 

  35. Reading, C. L., Brunson, K. W., Torrianni, M., and Nicolson, G. L., 1980, Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70. Proceedings of the National Academy of Sciences, U.S.A., 77, 5943–5947.

    Google Scholar 

  36. Recht, A., Silver, B., Schnitt, S., Connolly, J., Hellman, S., and Harris, J. R., 1985, Breast relapse following primary radiation therapy for early breast cancer. I. Classification, frequency and salvage. International Journal of Radiation Oncology, Biology and Physics, 11, 1271–1276.

    Google Scholar 

  37. Rotter, V., Wolf, D., and Nicolson, G. L., 1984, The expression of transformation-related protein p53 and p53-containing mRNA in murine RAW117 large cell lymphoma cells of differing metastatic potential. Clinical and Experimental Metastasis, 2, 199–204.

    Google Scholar 

  38. Schalkin, J. A., Eberling, S. B., Isaacs, J. T., Treiger, B., Bussemakers, M. J.G., deJong, M. E. M., and Van de Ven, W. J. M., 1988, Downmodulation of fibronectin messenger RNA in metastasizing rat prostatic cancer cells revealed by differential hybridization. Cancer Research, 48, 2042–2046.

    Google Scholar 

  39. Schnitt, S. J., Connolly, J. L., Recht, A., Siler, B., and Harris, J. R., 1985, Breast relapse following primary radiation therapy for early breast cancer. II. Detection, pathologic features and prognostic significance. International Journal of Radiation Oncology, Biology and Physics, 11, 1277–1284.

    Google Scholar 

  40. Sloane, B. F., and Honn, K. V., 1984, Cysteine proteinases and metastasis. Cancer Metastasis Reviews, 3, 349–363.

    Google Scholar 

  41. Steck, P. A., and Nicolson, G. L., 1983, Cell surface glycoproteins of 13762NF mammary adenocarcinoma clones of differing metastatic potentials. Experimental Cell Research, 147, 255–267.

    Google Scholar 

  42. Steeg, P. S., 1989, Search for metastasis suppressor genes. Invasion Metastasis, 9, 351–359.

    Google Scholar 

  43. Tao, T.-W., and Burger, M. M., 1982, Lectin-resistant variants of mouse melanoma cells. I. Altered metastasizing capacity and tumorigenicity. International Journal of Cancer, 29, 425–430.

    Google Scholar 

  44. Tarin, D., 1985, Clinical and experimental studies on the biology of metastasis. Biochimica et Biophysica Acta, 780, 227–235.

    Google Scholar 

  45. Weiss, L., 1979, Dynamic aspects of cancer cell populations in metastasis. American Journal of Pathology, 97, 601–608.

    Google Scholar 

  46. Welch, D. R., 1989, Factors involved in the development and maintenance of tumor heterogeneity. Carcinogenesis and Dietary Fat, edited by S. Abraham (New York: Martinus Nijhoff), pp. 279–304.

    Google Scholar 

  47. Welch, D. R., Aeed, P. A., and Estrada, J., 1988, Characterization of a model for locally recurring mammary tumors. II. Sensitivities to FUdR, Adriamycin and X-irradiation. Cancer Research, 48, 4549–4554.

    Google Scholar 

  48. Welch, D. R., Fabra, A., and Nakajima, M., 1990, Transforming growth factor-beta stimulates mammary adenocarcinoma cell invasion and metastatic potential. Proceedings of the National Academy of Sciences, U.S.A. (In press).

  49. Welch, D. R., Neri, A., and Nicolson, G. L., 1983, Comparison of ‘spontaneous’ and ‘experimental’ metastasis using rat 13762NF mammary adenocarcinoma metastatic cell clones. Invasion Metastasis, 3, 65–80.

    Google Scholar 

  50. Welch, D. R., and Tomasovic, S. P., 1985, The implications of tumor progression on clinical oncology. Clinical and Experimental Metastasis, 3, 151–188.

    Google Scholar 

  51. Weng, L., Russell, J., and Heinrickson, R. L., 1978, The covalent structure of bovine rhodanase. Journal of Biological Chemistry, 253, 8093–8101.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Welch, D.R., McClure, S.A., Aeed, P.A. et al. Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas. Clin Exp Metast 8, 533–551 (1990). https://doi.org/10.1007/BF00135876

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00135876

Keywords

Navigation